Crossmark

ICU admission for solid cancer patients treated with immune checkpoint inhibitors

Crossref DOI link: https://doi.org/10.1186/s13613-023-01122-z

Published Print: 2023

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Toffart, Anne-Claire https://orcid.org/0000-0003-4377-0227
Meert, Anne-Pascale

Wallet, Florent

Gibelin, Aude

Guisset, Olivier

Gonzalez, Frédéric

Seguin, Amélie

Kouatchet, Achille

Delaunay, Myriam

Debieuvre, Didier

Duchemann, Boris

Rousseau-Bussac, Gaëlle

Nyunga, Martine

Grimaldi, David

Levrat, Albrice

Azoulay, Elie

Lemiale, Virginie
Funding

Funding for this research was provided by:

Roche
License Information

Text and Data Mining valid from 2023-01-01

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: ICU admission for solid cancer patients treated with immune checkpoint inhibitors

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-023-01122-z

Content Type: article

Copyright: Copyright © 2023 The Author(s) 2023. Published by Elsevier Masson SAS